AzTrials
AzTrials

Wear of Articular Bearing Surface of Prosthetic JointNCT06426641

Polyethylene Wear Particle Analysis of TKA

An observational study of Wear of Articular Bearing Surface of Prosthetic Joint and Total Knee Arthroplasty, run by Osaka Metropolitan University at 2 sites in 2 countries.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study was to investigate whether polyethylene (Vitamin E-containing polyethylene), which has been newly introduced and widely used clinically as a biomaterial for tibial inserts in total knee arthroplasty, but whose mid- to long-term clinical results are still unknown, is more effective than… Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Polyethylene
Type of treatment
Medical device
How many people
90 participants
Where
2 sitesin 2 countries
Study dates
5 Dec 2023to 31 Dec 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing revision surgery

Who may be able to join

  • Patients undergoing revision knee arthroplasty within the study period
  • Patients over 20 years old
  • Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
  • Patients who have passed 2 years or more since their first total knee arthroplasty

Who cannot join

  • 1. Patients who are judged to be unsuitable as research subjects by the research physician

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • Mayo Clinic

    Rochester, Minnesota, 55905

Other trials in United States

Japan1 site
  • Osaka Metroplitan Univerity

    Osaka, 545-8585

Other trials in Japan

About this study

Official title: Polyethylene Wear Particle Analysis of Total Knee Arthroplasty -International Multicenter Study-

The purpose of this study was to investigate whether polyethylene (Vitamin E-containing polyethylene), which has been newly introduced and widely used clinically as a biomaterial for tibial inserts in total knee arthroplasty, but whose mid- to long-term clinical results are still unknown, is more effective than conventional polyethylene.

Our goal is to clarify through an international multi-center joint study using in vivo polyethylene wear particle analysis, which the investigators developed as a method to provide early feedback, as to whether polyethylene wear debris production in vivo can be reduced.

Read the detailed description

Anticipated medical contribution and significance In this study, the investigators investigate whether a newly introduced polyethylene (highly cross-linked polyethylene, vitamin E-containing polyethylene in vivo) can suppress wear debris production more than conventional polyethylene. If the newly introduced polyethylene can reduce wear debris production, it is expected to reduce failure of artificial joints in the future. However, if newly introduced polyethylene is actually increasing wear debris production, it could be an early alarm bell for surgeons around the world. In other words, the international and social impact of this research is extremely large.

Two unique requirements are necessary to carry out this research. Firstly, in vivo analysis of polyethylene wear particles is possible, and secondly, the number of surgical cases of revision knee arthroplasty targeted for investigation is large. The first requirement is that the applicants have published many English-language papers on in vivo polyethylene wear debris analysis, and that their facilities are the most suitable and fully capable of carrying out the analysis worldwide. be. The second requirement is that the investigators need to collaborate not only with our hospital but also with facilities that perform a large number of revision knee arthroplasty surgeries. Not only our hospital, but also our affiliated hospital, which is one of the facilities in Japan that performs the most knee joint surgeries (Naniwa Ikuno Hospital), and the hospital that performs the most knee joint surgeries worldwide (Mayo Clinic [USA]). , Hospital for Special Surgery [USA], Istituto Ortopedico Rizzoli [Italy]).

Research method In this study, the investigators conducted the following steps to determine the in vivo wear particles (number, size, and morphology) of conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose mid- to long-term results have not yet been clarified. Clarifying the difference [Figure 3].

Target of this research In this study, the investigators will focus on patients undergoing revision knee arthroplasty as a routine medical treatment.

First total joint replacement

  • 30 patients using polyethylene containing Vitamin E
  • 30 patients using conventional polyethylene (no highly cross-linking)
  • 30 patients using conventional polyethylene (with highly cross-linking)

Accumulation of periarticular tissue In this study, the investigators will focus on patients undergoing revision knee arthroplasty as a routine medical treatment.

The test will be conducted after obtaining approval from the ethics committee at each facility and obtaining informed consent. The pericapsular tissue, which is removed during surgery and usually discarded, is obtained and fixed in formalin fixative. The tissue will be transported to the Department of Orthopedic Surgery, Osaka Public University Graduate School of Medicine for analysis. International transportation of tissues requires outsourcing to specialized companies with experience in transporting tissues from overseas.

Isolation of polyethylene wear debris The collected tissue around the joint capsule is immersed in 5M NaOH at 65°C for 1 hour to decompose the protein. Make a sucrose layer (5, 10, 20%) in a 14ml tube (14PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the dissolved solution, and place in an ultracentrifuge (CP100a, P28S1014 rotor, Hitachi Koki). Ultracentrifuge at 28,000 rpm [103,7009g] for 3 hours at 4°C. Prepare an isopropanol layer (0.90 and 0.96 g/mL) in a 40 ml tube (40PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the upper layer of sucrose layer, and centrifuge at 28,000 rpm (103,7009 g ) and perform ultracentrifugation at 4°C for 1 hour. The isopropanol interlayer is collected to isolate polyethylene wear debris.

Analysis of polyethylene wear debris The isopropanol interlayer is filtered through a 0.1 μm polycarbonate filter (VCTP 013-00, Millipore Corporation, Bedford, MA). Dry the polycarbonate filter, fix it on an aluminum pedestal (M4, Nisshin EM Co, Ltd, Tokyo, Japan), and apply platinum coating (E-1030 ion sputter, Hitachi Science Systems Ltd, Tokyo, Japan). Observe the polyethylene wear particles on the polycarbonate filter using a scanning electron microscope (S4700SI, Hitachi Ltd, Tokyo, Japan), and analyze the following items using an image analyzer (Mac Scope, Mitani Co, Tokyo, Japan).

  • Number of polyethylene wear particles (number per 1g of tissue)
  • Size (Equivalent circle diameter [μm])
  • Shape (aspect ratio, roundness)

Comparison of iv vivo polyethylene wear powder morphology depending on polyethylene material The number, size, and form of polyethylene wear debris will be compared between conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose medium- to long-term results have not yet been clarified.

The investigators also investigated factors that affect polyethylene wear in vivo (age, height, weight, period from initial surgery to revision surgery, knee joint range of motion, knee prosthesis clinical score [Knee Society Score, University of California at Los Angeles activity score]).

Evaluation items (outcome) Main evaluation items: Polyethylene wear particle morphology (number of wear particles, equivalent circle diameter [㎛], aspect ratio, roundness) [Reason for setting primary endpoints] Because it is a standard evaluation item for evaluating polyethylene wear debris.

Secondary endpoints:

  • Body mass index
  • Knee joint range of motion
  • Clinical score (2011Knee Society Score, Knee injury and Osteoarthritis Outcome Score for Joint Replacement, University of California at Los Angeles activity score) [Reason for setting secondary endpoints] Because it may affect the production of polyethylene wear debris.

Planned number of research subjects and basis for setting it (including cases where the number of research subjects is set without relying on statistical grounds) Total 90 cases

  • 30 patients using polyethylene containing Vitamin E
  • 30 patients using conventional polyethylene (no high cross-linking)
  • 30 patients using conventional polyethylene (with high cross-linking) Rationale for setting: The target number of cases was determined from the number of cases at related institutions within the study period.
Being tested
Polyethylene
Keywords
Polyethylene wear particle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PolyethyleneDevice

    There is no intervention

Study groups in NCT06426641
Study groupRoleWhat they receive
polyethylene containing Vitamin Epolyethylene containing Vitamin E
Receives: Device: Polyethylene
conventional polyethylene (no highly cross-linking)conventional polyethylene (no highly cross-linking)
Receives: Device: Polyethylene
conventional polyethylene (with highly cross-linking)conventional polyethylene (with highly cross-linking)
Receives: Device: Polyethylene

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of polyethylene wear particles

    counts / g (tissue sample)

    Measured: Time of revision surgery

  2. Equivalent circle diameter of polyethylene wear particles

    Equivalent circle diameter (㎛)

    Measured: Time of revision surgery

  3. Aspect ratio of polyethylene wear particles

    Aspect ratio

    Measured: Time of revision surgery

  4. Roundness of polyethylene wear particles

    Roundness

    Measured: Time of revision surgery

Secondary outcomes (9)
  1. Body mass index

    kg/m2

    Measured: Time of revision surgery

  2. Knee joint extension angle

    degrees

    Measured: Time of revision surgery

  3. Knee joint flexion angle

    degrees

    Measured: Time of revision surgery

  4. 2011 Knee Society Score: An "Objective" Knee Score

    0(worse)-100(best)

    Measured: Time of revision surgery

  5. 2011 Knee Society Score: A Patient Satisfaction Score

    0(worse)-40(best)

    Measured: Time of revision surgery

  6. 2011 Knee Society Score: A Patient Expectation Score

    0(worse)-15(best)

    Measured: Time of revision surgery

  7. 2011 Knee Society Score: A Functional Activity Score

    0(worse)-100(best)

    Measured: Time of revision surgery

  8. Knee injury and Osteoarthritis Outcome Score for Joint Replacement

    0(worse)-100(best)

    Measured: Time of revision surgery

  9. University of California at Los Angeles activity score

    1(worse)-10(best)

    Measured: Time of revision surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2024
  2. Study start5 Dec 2023
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06426641
Sponsor's protocol ID
OMU 2023-108
Status last verified
Jan 2025
First submitted
16 May 2024
Last updated
17 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Minoda Y, Kobayashi A, Iwaki H, Iwakiri K, Inori F, Sugama R, Ikebuchi M, Kadoya Y, Takaoka K. In vivo analysis of polyethylene wear particles after total knee arthroplasty: the influence of improved materials and designs. J Bone Joint Surg Am. 2009 Nov;91 Suppl 6:67-73. doi: 10.2106/JBJS.I.00447. No abstract available.

    PubMed 19884413
  • Minoda Y, Kobayashi A, Iwaki H, Miyaguchi M, Kadoya Y, Ohashi H, Yamano Y, Takaoka K. Polyethylene wear particles in synovial fluid after total knee arthroplasty. Clin Orthop Relat Res. 2003 May;(410):165-72. doi: 10.1097/01.blo.0000063122.39522.c2.

    PubMed 12771827

Questions about this trial

What is this clinical trial studying?

An observational study of Wear of Articular Bearing Surface of Prosthetic Joint and Total Knee Arthroplasty, run by Osaka Metropolitan University at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 17 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Japan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of polyethylene wear particles (time frame: Time of revision surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06426641, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in